Search Results

There are 6114 results for: content related to: What's new in HCV genotype 2 treatment

  1. You have free access to this content
    How to optimize HCV therapy in genotype 2 patients

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 35–40, Eleonora Grassi and Alessio Aghemo

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12056

  2. You have free access to this content
    Optimal therapy of genotype-2 chronic hepatitis C: what's new?

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 21–26, Marc Bourlière, Souad Benali, Christelle Ansaldi, Gaelle Le Folgoc, Aurelie Riso and Laurence Lecomte

    Version of Record online : 22 DEC 2014, DOI: 10.1111/liv.12711

  3. You have free access to this content
    How to optimize current treatment of genotype 2 hepatitis C virus infection

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 13–17, Sebastián Marciano and Adrián C. Gadano

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12399

  4. You have free access to this content
    Current and future HCV therapy: do we still need other anti-HCV drugs?

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 4–10, Salvatore Petta and Antonio Craxì

    Version of Record online : 22 DEC 2014, DOI: 10.1111/liv.12714

  5. You have free access to this content
    Optimal therapy in genotype 4 chronic hepatitis C: finally cured?

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 27–34, Wael Abdel-Razek and Imam Waked

    Version of Record online : 22 DEC 2014, DOI: 10.1111/liv.12724

  6. You have free access to this content
    Optimal interferon-free therapy in treatment-experienced chronic hepatitis C patients

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 65–70, Joy Peter and David R. Nelson

    Version of Record online : 22 DEC 2014, DOI: 10.1111/liv.12718

  7. You have free access to this content
    Optimal therapy in hepatitis C virus liver transplant patients with direct acting antivirals

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 44–50, Audrey Coilly, Bruno Roche, Jean-Charles Duclos-Vallée and Didier Samuel

    Version of Record online : 22 DEC 2014, DOI: 10.1111/liv.12728

  8. Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood-donor screening

    Transfusion

    Volume 43, Issue 10, October 2003, Pages: 1452–1459, Leslie H. Tobler, Susan L. Stramer, Stephen R. Lee, Barbara L. Masecar, Jon E. Peterson, E. Anne Davis, William E. Andrews, Jaye P. Brodsky, Steven H. Kleinman, Bruce H. Phelps and Michael P. Busch

    Version of Record online : 26 SEP 2003, DOI: 10.1046/j.1537-2995.2003.00521.x

  9. You have free access to this content
    Optimal management of patients with chronic hepatitis C and comorbidities

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 35–43, Vincenzo Boccaccio and Savino Bruno

    Version of Record online : 22 DEC 2014, DOI: 10.1111/liv.12712

  10. You have free access to this content
    The impact of hepatitis C virus outside the liver: Evidence from Asia

    Liver International

    Zobair M. Younossi, Atsushi Tanaka, Yuichiro Eguchi, Young-Suk Lim, Ming-Lung Yu, Norifumi Kawada, Yock Young Dan, Craig Brooks-Rooney, Francesco Negro and Mario U. Mondelli

    Version of Record online : 10 NOV 2016, DOI: 10.1111/liv.13272

  11. You have free access to this content
    Meta-analysis: the outcome of anti-viral therapy in HCV genotype 2 and genotype 3 infected patients with chronic hepatitis

    Alimentary Pharmacology & Therapeutics

    Volume 28, Issue 4, August 2008, Pages: 397–404, A. ANDRIULLI, A. MANGIA, A. IACOBELLIS, A. IPPOLITO, G. LEANDRO and S. ZEUZEM

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1365-2036.2008.03763.x

  12. You have free access to this content
    Evolving concepts in primary sclerosing cholangitis

    Liver International

    Volume 32, Issue 3, March 2012, Pages: 352–369, Elisabeth Krones, Ivo Graziadei, Michael Trauner and Peter Fickert

    Version of Record online : 17 AUG 2011, DOI: 10.1111/j.1478-3231.2011.02607.x

  13. You have free access to this content
    Cure of HCV related liver disease

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 71–77, Mitchell L Shiffman and Yves Benhamou

    Version of Record online : 22 DEC 2014, DOI: 10.1111/liv.12734

  14. Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: A new marker of HCV infection closely associated with viremia

    Journal of Medical Virology

    Volume 45, Issue 4, April 1995, Pages: 415–422, R. Lesniewski, R. Johnson, J. Scheffel, B. Moore, G. Okasinski, R. Carrick, C. Van Sant, S. Desai and I. Mushahwar

    Version of Record online : 7 DEC 2005, DOI: 10.1002/jmv.1890450411

  15. You have full text access to this OnlineOpen article
    Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection

    Liver International

    Jordan J. Feld, Ira M. Jacobson, Mark S. Sulkowski, Fred Poordad, Fernando Tatsch and Jean-Michel Pawlotsky

    Version of Record online : 29 SEP 2016, DOI: 10.1111/liv.13212

  16. You have free access to this content
    Sorting out cirrhosis: mechanisms of non-response to hepatitis C therapy

    Liver International

    Volume 35, Issue 8, August 2015, Pages: 1923–1933, Saeed H. Al Marzooqi and Jordan J. Feld

    Version of Record online : 3 JUN 2015, DOI: 10.1111/liv.12861

  17. Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3

    Journal of Viral Hepatitis

    Volume 20, Issue 10, October 2013, Pages: 669–677, E. B. Tapper and N. H. Afdhal

    Version of Record online : 8 SEP 2013, DOI: 10.1111/jvh.12168

  18. You have free access to this content
    Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 88–102, Tarik Asselah and Patrick Marcellin

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02699.x

  19. Herbal hepatotoxicity: a tabular compilation of reported cases

    Liver International

    Volume 32, Issue 10, November 2012, Pages: 1543–1556, Rolf Teschke, Albrecht Wolff, Christian Frenzel, Johannes Schulze and Axel Eickhoff

    Version of Record online : 28 AUG 2012, DOI: 10.1111/j.1478-3231.2012.02864.x

  20. Management of HCV-2 and HCV-3 Non-Responders and Relapsers

    Clinical Dilemmas in Viral Liver Disease

    Giada Sebastiani, Alfredo Alberti, Pages: 43–46, 2010

    Published Online : 10 MAR 2010, DOI: 10.1002/9781444319590.ch9